• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.

作者信息

Sahay Rima Rakeshkumar, Shete Anita M, Sapkal Gajanan N, Deshpande Gururaj R, Shah Arti D, Kumar Sanjay, Abraham Priya, Yadav Pragya D

机构信息

Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India.

Diagnostic Virology Group, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India.

出版信息

Indian J Med Res. 2022 May-Jun;155(5&6):575-577. doi: 10.4103/ijmr.ijmr_1390_21.

DOI:10.4103/ijmr.ijmr_1390_21
PMID:35975349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9807192/
Abstract
摘要

相似文献

1
Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.印度古吉拉特邦一名接种疫苗后的医护人员感染感兴趣的新冠病毒卡帕变种（B.1.617.1）后病情减轻
Indian J Med Res. 2022 May-Jun;155(5&6):575-577. doi: 10.4103/ijmr.ijmr_1390_21.
2
One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.一年后：感染后医护人员的新冠病毒免疫反应及疫苗接种情况
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.016. Epub 2021 Jun 18.
3
[Vaccination of healthcare workers against COVID-19].医护人员的新冠病毒疫苗接种
Soins. 2021 May;66(855):10-13. doi: 10.1016/S0038-0814(21)00120-1.
4
Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.关于英国一家大型三级医疗中心医护人员新冠疫苗接种计划影响的早期观察。
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.027. Epub 2021 Apr 29.
5
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.先前存在的蜱传脑炎病毒抗体对严重急性呼吸综合征冠状病毒 2 没有中和作用：一项前瞻性医护人员研究。
Sci Rep. 2021 Dec 17;11(1):24198. doi: 10.1038/s41598-021-03685-y.
6
Transition of Antibody Titers after SARS-CoV-2 mRNA Vaccination in Japanese Healthcare Workers.日本医护人员接种 SARS-CoV-2 mRNA 疫苗后抗体效价的变化。
Jpn J Infect Dis. 2023 Jan 24;76(1):72-76. doi: 10.7883/yoken.JJID.2022.041. Epub 2022 Aug 31.
7
Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination.医护人员中 COVID-19 疫苗接种的相对有效性：3 剂与 2 剂疫苗接种。
J Korean Med Sci. 2022 Sep 5;37(35):e267. doi: 10.3346/jkms.2022.37.e267.
8
Post-vaccination SARS-CoV-2 infection among healthcare workers in tertiary care hospitals in Saudi Arabia: A case series.沙特阿拉伯三级保健医院医护人员接种疫苗后的 SARS-CoV-2 感染：病例系列研究。
J Infect Public Health. 2022 Jan;15(1):10-12. doi: 10.1016/j.jiph.2021.11.015. Epub 2021 Nov 19.
9
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.先前 SARS-CoV-2 感染和 COVID-19 疫苗接种对后续 COVID-19 发病率的影响：一项针对英国医护人员的多中心前瞻性队列研究——SIREN（Sarscov2 免疫与再感染评估）研究方案。
BMJ Open. 2022 Jun 28;12(6):e054336. doi: 10.1136/bmjopen-2021-054336.
10
Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers.接种时间影响医护人员观察性研究中 SARS-CoV-2 抗体反应。
J Biol Rhythms. 2022 Feb;37(1):124-129. doi: 10.1177/07487304211059315. Epub 2021 Dec 4.

本文引用的文献

1
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.印度各邦第二波疫情期间新冠突破感染样本的临床特征和基因组分析。
Viruses. 2021 Sep 7;13(9):1782. doi: 10.3390/v13091782.
2
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.印度马哈拉施特拉邦第二波新冠疫情中出现的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白突变，L452R、T478K、E484Q和P681R
Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.
3
Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals.
用Covishield™疫苗接种者和新冠康复后接种疫苗者的血清中和德尔塔变种。
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab119.
4
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees.用BBV152疫苗接种者的血清中和正在研究的变异株B.1.617.1
Clin Infect Dis. 2022 Jan 29;74(2):366-368. doi: 10.1093/cid/ciab411.
5
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.加利福尼亚州医护人员接种疫苗后感染新冠病毒
N Engl J Med. 2021 May 6;384(18):1774-1775. doi: 10.1056/NEJMc2101927. Epub 2021 Mar 23.
6
Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India.在从南非和坦桑尼亚前往印度的旅行者中检测到输入性严重急性呼吸综合征冠状病毒2（SARS-CoV-2）V501Y.V2变体（B.1.351）。
Travel Med Infect Dis. 2021 May-Jun;41:102023. doi: 10.1016/j.tmaid.2021.102023. Epub 2021 Mar 14.
7
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.灭活新冠病毒疫苗BBV152的安全性和免疫原性：一项双盲、随机、多中心2期试验的中期结果以及一项双盲、随机1期试验的3个月随访
Lancet Infect Dis. 2021 Jul;21(7):950-961. doi: 10.1016/S1473-3099(21)00070-0. Epub 2021 Mar 8.
8
Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage.从英国旅行者中分离和鉴定到的新型 SARS-CoV-2 变异株：B.1.1.7 谱系的 VUI-202012/01。
J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taab009.
9
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.用于检测抗 SARS-CoV-2 IgG 的本土 IgG ELISA 的开发。
Indian J Med Res. 2020 May;151(5):444-449. doi: 10.4103/ijmr.IJMR_2232_20.
10
Development of transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India.转录RNA作为印度SARS-CoV-2实验室诊断阳性对照的开发。
Indian J Med Res. 2020;151(2 & 3):251-254. doi: 10.4103/ijmr.IJMR_671_20.